Product Information
CLONAZEPAM 0.5 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.0199 per EA under NDC 60687086101. Its NADAC has been published 63 times since Apr 16, 2025.
Strength
.5 mg/1
Manufacturer
American Health PackagingNDC
60687086101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077856On Market Since
3/20/2025
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 0.5 MG TABLET has been published 63 times since Apr 16, 2025, and over the history we have for it it has declined 8.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0199 per EA |
|---|---|
| All-time high | $0.0224 (Sep 10, 2025) |
| All-time low | $0.0198 (May 20, 2026) |
| 52-week high | $0.0224 |
| 52-week low | $0.0198 |
| Median price | $0.0218 |
| Average price | $0.0214 |
| Largest weekly change | -3.5% (Feb 18, 2026) |
| Weeks tracked | 63 |
| Tracking since | Apr 16, 2025 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLONAZEPAM 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 0.5 MG TABLET, manufactured by American Health Packaging, is $0.0199 per EA (NDC 60687086101), effective Jun 24, 2026.
How has the price of CLONAZEPAM 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 0.5 MG TABLET has declined 8.7%. It has been tracked across 63 weekly CMS publications since Apr 16, 2025.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 0.5 MG TABLET?
Since Apr 16, 2025, the NADAC for CLONAZEPAM 0.5 MG TABLET has ranged from a low of $0.0198 (May 20, 2026) to a high of $0.0224 (Sep 10, 2025), with a median of $0.0218 per EA.
Are there cheaper alternatives to CLONAZEPAM 0.5 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as CLONAZEPAM 0.5 MG TABLET, but none are currently priced below it.
Who manufactures CLONAZEPAM 0.5 MG TABLET?
CLONAZEPAM 0.5 MG TABLET (NDC 60687086101) is labeled by American Health Packaging, and CMS classifies it as a generic product.
Related Drugs
Same classification